Specialized astrocytes mediate glutamatergic gliotransmission in the CNS
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. / de Ceglia, Roberta; Ledonne, Ada; Litvin, David Gregory; Lind, Barbara Lykke; Carriero, Giovanni; Latagliata, Emanuele Claudio; Bindocci, Erika; Di Castro, Maria Amalia; Savtchouk, Iaroslav; Vitali, Ilaria; Ranjak, Anurag; Congiu, Mauro; Canonica, Tara; Wisden, William; Harris, Kenneth; Mameli, Manuel; Mercuri, Nicola; Telley, Ludovic; Volterra, Andrea.
In: Nature, Vol. 622, 2023, p. 120-129.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Specialized astrocytes mediate glutamatergic gliotransmission in the CNS
AU - de Ceglia, Roberta
AU - Ledonne, Ada
AU - Litvin, David Gregory
AU - Lind, Barbara Lykke
AU - Carriero, Giovanni
AU - Latagliata, Emanuele Claudio
AU - Bindocci, Erika
AU - Di Castro, Maria Amalia
AU - Savtchouk, Iaroslav
AU - Vitali, Ilaria
AU - Ranjak, Anurag
AU - Congiu, Mauro
AU - Canonica, Tara
AU - Wisden, William
AU - Harris, Kenneth
AU - Mameli, Manuel
AU - Mercuri, Nicola
AU - Telley, Ludovic
AU - Volterra, Andrea
N1 - Publisher Copyright: © 2023, The Author(s).
PY - 2023
Y1 - 2023
N2 - Multimodal astrocyte–neuron communications govern brain circuitry assembly and function1. For example, through rapid glutamate release, astrocytes can control excitability, plasticity and synchronous activity2,3 of synaptic networks, while also contributing to their dysregulation in neuropsychiatric conditions4–7. For astrocytes to communicate through fast focal glutamate release, they should possess an apparatus for Ca2+-dependent exocytosis similar to neurons8–10. However, the existence of this mechanism has been questioned11–13 owing to inconsistent data14–17 and a lack of direct supporting evidence. Here we revisited the astrocyte glutamate exocytosis hypothesis by considering the emerging molecular heterogeneity of astrocytes18–21 and using molecular, bioinformatic and imaging approaches, together with cell-specific genetic tools that interfere with glutamate exocytosis in vivo. By analysing existing single-cell RNA-sequencing databases and our patch-seq data, we identified nine molecularly distinct clusters of hippocampal astrocytes, among which we found a notable subpopulation that selectively expressed synaptic-like glutamate-release machinery and localized to discrete hippocampal sites. Using GluSnFR-based glutamate imaging22 in situ and in vivo, we identified a corresponding astrocyte subgroup that responds reliably to astrocyte-selective stimulations with subsecond glutamate release events at spatially precise hotspots, which were suppressed by astrocyte-targeted deletion of vesicular glutamate transporter 1 (VGLUT1). Furthermore, deletion of this transporter or its isoform VGLUT2 revealed specific contributions of glutamatergic astrocytes in cortico-hippocampal and nigrostriatal circuits during normal behaviour and pathological processes. By uncovering this atypical subpopulation of specialized astrocytes in the adult brain, we provide insights into the complex roles of astrocytes in central nervous system (CNS) physiology and diseases, and identify a potential therapeutic target.
AB - Multimodal astrocyte–neuron communications govern brain circuitry assembly and function1. For example, through rapid glutamate release, astrocytes can control excitability, plasticity and synchronous activity2,3 of synaptic networks, while also contributing to their dysregulation in neuropsychiatric conditions4–7. For astrocytes to communicate through fast focal glutamate release, they should possess an apparatus for Ca2+-dependent exocytosis similar to neurons8–10. However, the existence of this mechanism has been questioned11–13 owing to inconsistent data14–17 and a lack of direct supporting evidence. Here we revisited the astrocyte glutamate exocytosis hypothesis by considering the emerging molecular heterogeneity of astrocytes18–21 and using molecular, bioinformatic and imaging approaches, together with cell-specific genetic tools that interfere with glutamate exocytosis in vivo. By analysing existing single-cell RNA-sequencing databases and our patch-seq data, we identified nine molecularly distinct clusters of hippocampal astrocytes, among which we found a notable subpopulation that selectively expressed synaptic-like glutamate-release machinery and localized to discrete hippocampal sites. Using GluSnFR-based glutamate imaging22 in situ and in vivo, we identified a corresponding astrocyte subgroup that responds reliably to astrocyte-selective stimulations with subsecond glutamate release events at spatially precise hotspots, which were suppressed by astrocyte-targeted deletion of vesicular glutamate transporter 1 (VGLUT1). Furthermore, deletion of this transporter or its isoform VGLUT2 revealed specific contributions of glutamatergic astrocytes in cortico-hippocampal and nigrostriatal circuits during normal behaviour and pathological processes. By uncovering this atypical subpopulation of specialized astrocytes in the adult brain, we provide insights into the complex roles of astrocytes in central nervous system (CNS) physiology and diseases, and identify a potential therapeutic target.
U2 - 10.1038/s41586-023-06502-w
DO - 10.1038/s41586-023-06502-w
M3 - Journal article
C2 - 37674083
AN - SCOPUS:85169879166
VL - 622
SP - 120
EP - 129
JO - Nature Genetics
JF - Nature Genetics
SN - 1061-4036
ER -
ID: 366989738